89bio Clinical Study Site

Graz A-8036

1 studies enrolling now · 2 studies all time

What they study most

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Severe Hypertriglyceridemia

Studies at this site

• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) — Recruiting now
• To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia — Completed